NCT07240805Not yet recruiting
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Digital Health Technologies For Monitoring Disease Symptoms in Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
Progressive supranuclear palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB) are severe neurodegenerative diseases that cause significant motor impairment impacting daily function. Researchers at BioSensics, Johns Hopkins School of Medicine, Massachusetts General Hospital and their collaborators aim to conduct an analytical and clinical validation of wearable-based digital health technologies for monitoring upper and lower limb function in PSP, MCI-LB and DLB that could enable frequent, at-home monitoring and be incorporated into future clinical trials.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 11 Nov 2025
- Start date
- 15 Jan 2027
- Primary completion date
- 1 Dec 2028
- Lead sponsor
- BioSensics
- Diseases
- Lewy body dementia
- NCT number
- NCT07240805
What you commit to
- Study type: Observational
- Planned participants: 60
- From 15 Jan 2027 to the primary completion date, 1 Dec 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any neurological, medical, or psychiatric condition that would preclude or confound participation in study activities based on the investigator's judgment.
- History of frequent falls defined as more than 5 falls per month, will not be eligible to participate in the study.
Who the study is looking for
- Male and female participants aged 40-89 meeting clinical diagnostic criteria for probable PSP, probable MCI-LB or probable DLB.
- Able to be present for all study procedures, complete questionnaires and assist during home data collection.
- Eligible participants must be fluent in reading and speaking English and must be capable of providing informed consent based on the principal investigator's judgment.
- Must have a caregiver or study partner who is willing and able to assist with all study-related procedures.
- Ambulatory (able to take 10 steps with minimal support such as use of a cane)
Age in the registry: 40 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Johns Hopkins University School of Medicine Coordinator of this site? Confirm its status | Lutherville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.